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icies, IPCO obtained baseline data on SAP practices of surgeons by reviewing
charts of post-surgery patients for four (4) consecutive weeks by utilizing a
form provided by WHO. Seventy five operations were reviewed. Wound class
were classified, SAP practices and compliance of surgeons analyzed.
Results: Of the 75 operations, 37% 40%, 8%, 15% were wound class 1,2,3,4
respectively. SAP were given to 39% of wound class I, 70% of wound class
2, 67% of wound class 3 and 36% of wound class 4.Fifty three percent
(53%) adhere to right timing within 60 minutes before incision with simple
dose only were given to 44%; 40% continued post operatively. In 16% of cases,
SAP was ordered after the operations.Table I Shows the classifications of the 75 operations by wound class
and SAP practice.
Wound class No (%) No. SAP applied
1 28(37) 11(39)
2 30(40) 21(70)
3 6(8) 4(67)
4 11(15) 4(36)
75(100) 40(53)Table II Compliance of surgeons to SAP recommendations.
Timing %
Within 60 mins 53
Dosing
Single dose 44
Post operative dose only 16
Continued post operative 40Conclusion: The preimplementation survey revealed that only 53% of pa-
tients received SAP at the right timing, 44% received single dose but in
44%, antibiotic was continued after operation. A unified guideline for imple-
mentation of SAP is necessary to improve prophylaxis practices of surgeons.PS 1-004
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Purpose: Fluoroquinolone-resistant non-typhoidal Salmonella is increasing
worldwide. This study was conducted to evaluate whether fluoroquinolones
are still appropriately therapeutic options for non-typhoidal Salmonella in-
fections in southern Taiwan.
Methods: This was a retrospective study at a regional hospital in southern
Taiwan. From 2009 to 2013, all non-typhoidal Salmonella reported from clin-
ical laboratory were enrolled in this study. If multiple isolates were identi-
fied from the same patient during the same hospitalization period, only
the first isolate was enrolled. Antimicrobial susceptibility testing was done
by disk diffusion method. The tested antibiotics included ampicillin, ceftri-
axone, levofloxacin, and trimethoprim-sulfamethoxazole (TMP-SMX). The re-
sults were interpreted according to the criteria recommended by the Clinical
Laboratory Standards Institute. Intermediate result was regard as resistant
in this study.
Results: A total of 122 isolates of non-typhoidal Salmonella were enrolled in
this study. Of the 29 isolates in 2009, the susceptibility rates of ampicillin,
ceftriaxone, levofloxacin, and TMP-SMX were 69%, 96.6%, 100%, and 89.7%,
respectively. Of the 17 isolates in 2010, those were 70.6%, 100%, 100%,
and 88.2%, respectively. Of the 25 isolates in 2011, those were 60%, 100%,
100%, and 76%, respectively. Of the 22 isolates in 2012, those were 54.6%,
95.5%, 100%, and 90.9%, respectively. Of the 29 isolates in 2013, those
were 58.6%, 100%, 100%, and 82.8%, respectively.
Conclusions: As a result of this study, levofloxacin has a susceptibility rate of
100% for non-typhoidal Salmonella from 2009 to 2013, indicating that fluoro-
quinolones are still appropriately therapeutic options for non-typhoidal Sal-
monella infections in southern Taiwan.PS 1-005
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Purpose: Gram-positive coccus (GPC) bacteremia is common clinically, but
it takes several days to have final identification of microorganism and its
antimicrobial susceptibility. Among all the GPCs, early detection of methi-
cillin-resistant Staphylococcus aureus (MRSA) and shorten the duration of
inadequate treatment is a target for decades. The objective of this study
is to apply polymerase chain reaction to rapidly identify MRSA bacteremia
and analyze its effect.
Methods: The study was performed at Far Eastern Memorial Hospital from
July 2012 to June 2014. All cases with blood culture yielding GPC in clusters
and a time to positive blood culture less than 20 hours were considered for
inclusion. BACTEC 9240 automated blood culture system was used. Conven-
tional identification and susceptibility test of GPC was performed, in parallel
to polymerase chain reaction (Cepheid Xpert MRSA/SA Blood Culture Assay),
if patients agreed to join the study. After knowing the PCR results, infectious
disease physician contacts the primary physician and suggests the antimicro-
bial agent. Outcome of patients received PCR was compared to a control
group of patients not receiving PCR.
Results: Eighty-three patients with GPC bacteremia were enrolled, including
36 cases of methicillin- susceptible Staphylococcus aureus (MSSA), 28 of
coagulase negative Staphylococcus (CoNS), and 19 of MRSA. The median
time to final report was 30.6 hours, compared to 84.4 hours with conven-
tional method. The concordance rate of PCR and conventional methods
was 96%. Knowing the PCR result resulted in 24 cases antimicrobial modifica-
tion (29%). We compared 55 patients received PCR with SA bacteremia to a
control group (69 patients) with similar clinical parameters. The chances of
adequate empirical therapy within 48 hours were 73% in the PCR group and
77% in the control group. The 30 day mortality rates were 15% and 10%,
respectively. In a survival analysis combined these two groups, only MRSA
infection had a borderline significance of increased mortality (p Z 0.06).
Performance of PCR did not affect the outcome of patients.
Conclusion: Application of PCR for GPC bacteremia could shorten the time
to final microbiological report for 54 hours and decrease the time of inade-
quate empirical therapy. However, the effect on patients’ outcome could
not be demonstrated in this study.PS 1-006
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Purpose: According to United States Centers for Disease Control Prevention
of surgical site infection clinical guidelines stated in 1999: prophylactic an-
tibiotics must be given within 60 minutes of the operation according to pa-
tient body weight administered relative dose. Cephalosporins and other first
line class were the major prophylactic antibiotics in intravenous route based
on the principle of not more than one day use, such as during surgery more
than 2e4 hours, or excessive bleeding, according to the pharmacokinetics
needing additional antibiotics. Prophylactic antibiotics can reduce surgical
wound infection.
Methods: This reports were divided according to the structure of the surface
quality control processes, procedures and results of surface surface clean
surgical antibiotic prophylaxis to share the use of monitoring mechanisms
to construct the experience:
A. Structures: 1. An increase in the revised “clean surgical antibiotic prophy-
laxis monitoring methods and processes”, 2. Discussing with the Infectious
